Clinical Trial Update: FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind trial evaluating FOLFOX-HAIC plus lenvatinib and toripalimab versus FOLFOX-HAIC plus lenvatinib in advanced hepatocellular ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• FOLFOX-HAIC
• Lenvatinib (lenvatinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 3 | Status: RECRUITING